chlortetracycline has been researched along with Pasteurellosis--Pneumonic* in 2 studies
2 other study(ies) available for chlortetracycline and Pasteurellosis--Pneumonic
Article | Year |
---|---|
Use of chlortetracycline for treatment of new feedlot cattle.
Two 56-d shipping fever trials of similar design were conducted the same season (fall) at Kansas State University (KSU) and at Purdue University (PU) to compare various levels of chlortetracycline (0 or 350 mg X head-1 X d-1 continuously or 1, 2 or 4 g X head-1 X d-1 for the first 14 d). Weanling crossbred steer calves were utilized (210 head of Angus X Simmental, averaging 197 kg, at KSU; 268 head of Angus X Hereford, averaging 192 kg, at PU). For the first 28 d in the KSU trial (October 13 to December 8), cattle that received 4 g X head-1 X d-1 the first 14 d gained more rapidly (P less than .05) than cattle fed 350 mg X head-1 X d-1 continuously or than the controls that received no chlortetracycline (CTC; 1.05 vs .92 or .93 kg/d, respectively). Cattle that received 4 g CTC X head-1 X d-1 for the first 14 d required less (P less than .05) dry matter per kg gain than steers that received 350 mg X head-1 X d-1 continuously over the 56-d period. In the PU trial (October 6 through December 1), all CTC treatments resulted in increased feed efficiency (P less than .05) over the controls through 28 d, and the 4 g X head-1 d-1 for 14 d and 350 mg X head-1 X d-1 continuously, improved feed efficiency over the other groups for the 56-d period.(ABSTRACT TRUNCATED AT 250 WORDS) Topics: Animals; Body Weight; Cattle; Cattle Diseases; Chlortetracycline; Male; Pasteurella Infections; Pasteurellosis, Pneumonic | 1986 |
Mass medication in reducing shipping fever-bovine respiratory disease complex in highly stressed calves.
One thousand and eighty-five newly received, stressed calves were used in studies to determine the effectiveness of certain mass medication procedures for reducing morbidity from shipping fever-bovine respiratory disease complex. In two experiments, im injections of oxytetracycline at 11 mg/kg body wt for 3 successive days reduced treatment days/calf purchased 21 (P less then .05) and 31% (P less than .05). Oral administration of 150 mg of sulfadimethoxine/kg body wt reduced treatment days/calf purchased 20 (P less than .05) and 54% (P less than .05) in the same two experiments. When sulfadimethoxine followed oxytetracycline on the third injection day an 81% reduction in treatment days/calf purchased was obtained, indicating an additive effect of the two drugs. The use of long acting oxytetracycline and sustained release sulfadimethoxine at the time of processing resulted in a 90% reduction in treatment days/calf purchased (P less than .01) and required only one handling of the calves for mass medication purposes. Topics: Animals; Cattle; Cattle Diseases; Chlortetracycline; Drug Therapy, Combination; Male; Oxytetracycline; Pasteurella Infections; Pasteurellosis, Pneumonic; Respiratory Tract Infections; Sulfadimethoxine; Transportation | 1983 |